Mood changes during perimenopause and menopause are among the most consistently underrecognized and underattributed symptoms of the hormonal transition. Women experiencing new or worsening irritability, anxiety, emotional reactivity, or low mood during their 40s and early 50s are more likely to be referred to a therapist, prescribed an antidepressant independently of any hormonal evaluation, or told that stress is the cause — than to have the hormonal dimension of their mood changes explicitly identified and addressed.
This is not a criticism of mental health care or antidepressant treatment, both of which have important roles. It is a recognition that mood changes during the menopausal transition frequently have a direct hormonal driver that is the primary cause — and that addressing the hormonal cause produces mood improvements that psychological interventions or antidepressants alone cannot fully replicate.
The menopausal transition is a period of unique neurobiological vulnerability for mood dysregulation in susceptible women. The fluctuating and declining estrogen of perimenopause disrupts the serotonin, norepinephrine, and GABA systems that regulate mood — producing mood instability that can precede recognized menopause symptoms by years. Understanding this mechanism clarifies both why these symptoms occur and why hormonal management is often the most effective first-line intervention.
Mood changes in perimenopause and menopause present across a wide spectrum. The following reflects the range of mood-related symptoms most commonly associated with the hormonal transition.
- Irritability that is disproportionate to circumstances — a shorter fuse than usual, reactions that feel out of character
- Emotional reactivity — heightened sensitivity to situations that previously would not have produced significant emotional response
- Anxiety — new onset or worsening anxiety, including a sense of unease or impending worry without a specific trigger
- Low mood or depressive symptoms — persistent sadness, reduced motivation, or loss of interest in activities previously enjoyed
- Mood swings — rapid shifts between emotional states that feel unpredictable and are distressing to the woman experiencing them and to those around her
- Tearfulness — crying more easily or more frequently than before
- A general sense of not feeling like oneself — the experience of emotional responses that feel unfamiliar or out of proportion
- Difficulty concentrating or a sense of mental fogginess that compounds emotional symptoms
- Increased sensitivity to stress — situations that previously felt manageable now feel overwhelming
- Mood symptoms that are worst in the premenstrual phase of irregular perimenopause cycles
- Night sweat-driven sleep disruption that produces mood effects through sleep deprivation
Mood changes that are new, worsening, or out of character during the menopausal transition deserve a clinical evaluation that specifically considers the hormonal contribution — not simply a referral for psychological care without first addressing the physiological driver.
Most hormonal mood symptoms are addressed through a scheduled evaluation. Please seek more immediate support if you experience:
- Thoughts of self-harm or suicidal ideation — contact a mental health crisis line, your physician, or go to the nearest emergency room
- Severe depression that is interfering with basic daily functioning
- A mood change that feels like a psychiatric emergency rather than the typical hormonal mood variability described on this page
Mood changes in the menopausal transition are not simply psychological responses to life changes — they have well-characterized neurobiological mechanisms that reflect the direct effects of estrogen fluctuation and decline on mood-regulating brain systems.
Estrogen and Serotonin — A Direct Connection
Estrogen directly modulates serotonin synthesis, receptor density, and serotonin transporter activity in the brain. In estrogen-replete women, estrogen supports robust serotonergic function, contributing to mood stability. As estrogen fluctuates and declines during perimenopause, serotonin system function becomes less stable — producing the mood instability, irritability, and low mood that characterize the hormonal transition for susceptible women. This direct neurobiological relationship explains why estrogen therapy improves mood in perimenopausal women even in the absence of significant depression, and why mood changes often improve substantially with hormonal management.
Estrogen and GABA — Anxiety and Emotional Reactivity
GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the brain and is central to regulation of anxiety and emotional reactivity. Estrogen enhances GABAergic function through its effects on neurosteroid metabolism. As estrogen declines, the GABAergic dampening of anxiety circuitry becomes less effective, contributing to the new-onset or worsening anxiety, emotional sensitivity, and sense of being easily overwhelmed that many perimenopausal women describe. This mechanism also explains why panic attacks can develop or worsen during perimenopause in susceptible women.
Sleep Deprivation as a Mood Amplifier
Night sweats and sleep disruption from vasomotor symptoms produce a secondary layer of mood effects through the well-documented consequences of sleep deprivation on emotional regulation. Sleep-deprived individuals have heightened emotional reactivity, reduced frustration tolerance, increased anxiety, and lower mood thresholds — all of which compound the direct hormonal mood effects of estrogen decline. For women whose mood symptoms are significantly driven by sleep disruption from night sweats, effective management of the vasomotor symptoms often produces secondary improvement in mood that is as significant as the direct hormonal effect.
Perimenopause vs. Postmenopause — When Mood Symptoms Are Worst
Research consistently shows that the highest risk period for mood symptoms is perimenopause — the transitional phase characterized by estrogen fluctuation — rather than postmenopause, when estrogen levels are low but stable. Rapidly fluctuating estrogen levels appear to be more destabilizing to mood-regulating brain systems than consistently low estrogen. This explains why many women report that their mood improves after the final period and estrogen levels stabilize at a lower baseline, while the perimenopausal years were the most emotionally turbulent. It also explains why mood symptoms can develop in women who are still having periods and who do not yet recognize themselves as being in perimenopause.
Management of mood changes during the menopausal transition is led by Dr. Ramona D. Andrei, MD, PhD, FACOG — with an approach that addresses the hormonal contribution directly while supporting coordination with mental health care when indicated.
Hormonal Management
For perimenopausal women with mood symptoms driven by estrogen fluctuation, hormonal management — either hormone therapy or continued hormonal contraception that stabilizes the hormonal environment — addresses the underlying cause directly. Estrogen has demonstrated efficacy for perimenopausal mood symptoms that exceeds placebo in clinical studies. For women whose mood symptoms are clearly in the context of the menopausal transition, hormonal management is often the most effective first-line approach before or alongside psychiatric treatment.
Vasomotor Symptom Management
When mood symptoms are significantly driven by sleep deprivation from night sweats, effective management of the vasomotor symptoms — with either hormonal or non-hormonal options — produces secondary mood improvement by restoring sleep quality. This component of mood management is often overlooked when mood is treated in isolation from the sleep disruption that is driving or compounding it.
Coordination With Mental Health Care
For women with significant mood symptoms that warrant psychological or psychiatric evaluation — particularly those with moderate to severe depression or anxiety that may have a component beyond the hormonal — Dr. Andrei coordinates with mental health providers as part of a comprehensive management approach. Hormonal management and psychological or pharmacological mental health treatment are complementary, not competing, approaches in many patients.
The experience of not feeling like yourself during the menopausal transition — the irritability, the emotional reactivity, the anxiety or low mood that feel foreign and out of character — is one of the most disorienting aspects of hormonal change. It can affect relationships, work, self-perception, and quality of life in profound ways. And it is consistently undertreated because it is consistently underattributed to its hormonal cause.
A clinical evaluation that specifically considers the hormonal contribution to your mood changes is the starting point for a treatment plan that addresses the right target. Dr. Ramona D. Andrei and the team at Lapeer Women’s Health are here for that evaluation — at both our Lapeer and Rochester Hills offices, without a referral required.
Mood Changes in Menopause
Our team at Lapeer Women’s Health evaluates the hormonal contribution to mood changes and offers individualized management at both our Lapeer and Rochester Hills offices. No referral required.
Schedule a Gynecologic VisitThe information on this page is for educational purposes only and does not constitute medical or mental health advice. If you are experiencing a mental health emergency or thoughts of self-harm, call 988 (Suicide & Crisis Lifeline) or go to the nearest emergency room. Content reviewed by Dr. Ramona D. Andrei, MD PhD FACOG.
Gynecologic care for women of every age
Lapeer Women’s Health — Rochester Hills
2710 S Rochester Rd, Suite 2
Rochester Hills, MI 48307
Serving patients in Lapeer, Rochester Hills, and surrounding communities throughout Southeast Michigan.